SCHEMBL9971103

SCHEMBL9971103

CC[Si](CC)(CC)OC[C@H]1CO1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 10/20 0.43
TDP1 Q9NUW8 3/20 0.41
TSHR P16473 5/20 0.40
MAPK1 P28482 1/20 0.40
GLA P06280 1/20 0.34
TP53 P04637 4/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
HIF1A Q16665 2/20 0.32
CYP3A4 P08684 2/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
KMT2A Q03164 1/20 0.32
PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15095089 1.00 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL11659742 0.77 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL812694 0.77
SCHEMBL647425 0.77 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL10900694 0.76 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL23521486 0.76 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL3856312 0.74 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL8622001 0.74 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL2783666 0.74 TSHR (0.46) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1
SCHEMBL752412 0.73 TSHR (0.46) SMN1; SMN2ALDH1A1TDP1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2022775-B1 Trihydroxy polyunsaturated eicosanoids UNIV SOUTHERN CALIFORNIA (US) 2014-10-15 EP disclosed
US-8802874-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-08-12 US disclosed
US-20130296590-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES NATIONAL INSTITUTES OF HEALTH 2013-11-07 US disclosed
US-8461201-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-06-11 US disclosed
US-20120157700-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2012-06-21 US disclosed
US-20110237545-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2011-09-29 US disclosed
US-7902257-B2 Trihydroxy polyunsaturated eicosanoid UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2011-03-08 US disclosed
US-20090291916-A1 Trihydroxy Polyunsaturated Eicosanoid UNIVERSITY OF SOUTHERN CALIFORNIA 2009-11-26 US disclosed
US-7582785-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237545-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES ALOX5, ALOX15, ALOX15B SMN1; SMN2 4587/4885ALDH1A1 1027/4885TDP1 3414/4885
US-20130296590-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES ALOX5, ALOX15, ALOX15B SMN1; SMN2 4587/4885ALDH1A1 1027/4885TDP1 3414/4885
US-20090291916-A1 Trihydroxy Polyunsaturated Eicosanoid ALOX5, ALOX15, ALOX15B SMN1; SMN2 4531/4885ALDH1A1 1023/4885TDP1 3485/4885
US-20120157700-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES ALOX5, ALOX15, ALOX15B SMN1; SMN2 4587/4885ALDH1A1 1027/4885TDP1 3414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.